The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, specifically for adults aged 65 and older and individuals aged 12-64 years with underlying health conditions as defined by the Centers for Disease Control and Prevention.
FDA Approves Moderna's Next-Gen COVID Vaccine With Age Limits